Herbas VPB

Print
EN | LT
LT - COMBINATION THERAPY FOR TREATING CANCER WITH A POXVIRUS EXPRESSING A TUMOR ANTIGEN AND A MONOCLONAL ANTIBODY AGAINST TIM-3
EN - COMBINATION THERAPY FOR TREATING CANCER WITH A POXVIRUS EXPRESSING A TUMOR ANTIGEN AND A MONOCLONAL ANTIBODY AGAINST TIM-3

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/00
A61K 39/395
European patent
(11) Number of the document 3142689
(13) Kind of document T
(96) European patent application number 15724454.2
Date of filing the European patent application 2015-05-08
(97) Date of publication of the European application 2017-03-22
(45) Date of publication and mention of the grant of the patent 2020-11-11
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2015/029885
Date 2015-05-08
PCT application publication
(87) Number WO 2015/175340
Date 2015-11-19
Priority applications
(30) Number Date Country code
201461992771 P 2014-05-13 US
Inventors
(72)
FOY, Susan, US
MANDL, Stefanie, US
ROUNTREE, Ryan, US
Grantee
(73) Bavarian Nordic A/S, Hejreskovvej 10A, 3490 Kvistgaard, DK
Title
(54) COMBINATION THERAPY FOR TREATING CANCER WITH A POXVIRUS EXPRESSING A TUMOR ANTIGEN AND A MONOCLONAL ANTIBODY AGAINST TIM-3
  COMBINATION THERAPY FOR TREATING CANCER WITH A POXVIRUS EXPRESSING A TUMOR ANTIGEN AND A MONOCLONAL ANTIBODY AGAINST TIM-3